Skip to main content
. 2017 Aug 7;8(39):66293–66304. doi: 10.18632/oncotarget.19973

Figure 2. Kaplan-Meier curves of progression-free survival (PFS) in patients with pemetrexed-treated lung adenocarcinoma.

Figure 2

PD-L1 expression (A), PD-1 expression (B), and TS expression (C) of patients in correlation with PFS. The P value for the difference between the two was determined by the log-rank test.